Aard
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
42075 Avenida Alvarado, Temecula, Califo...Phone Number
(951) 296-0844Website
www.aard.comRevenue
<$5 MillionIndustry
About Aard
Aard Org Chart
Is Aard your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Aard is spiking on competitors!
Earning: See what the market has to say on Aard recently announced quarterly report
Check if Aard has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Aard launches new products
Website visits: Recent activity has been detected on your website
Click to see if Aard had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aard
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Aard has new funding data
Aard, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Aard as Masked Content
Find more new buyers
Compare Similar Companies to Aard
Compare insights from companies similar to Aard, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aard is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aard is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aard.
Aard financials insights
Gather financial insights about Aard, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$150K
Debt
$233K
Aard Tech Stack
A closer look at the technologies used by Aard
Aard News & Media
AARD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aardvark Therapeutics Securities Lawsuit - Contact SueWallSt
A securities class action alleges Aardvark Therapeutics overstated ARD-101's safety profile; Wall Street price targets collapsed from as high as $29 to $7 after the Phase 3 HERO trial was paused and the FDA imposed a clinical hold A securities class action alleges Aardvark Therapeutics overstated ARD-101's safety profile; Wall Street price targets collapsed from as high as $29 to $7 after the Phase 3 HERO trial was paused and the FDA imposed a clinicalDeadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. ("Aardvark" or the "Company") (NASDAQ: AARD) securities between February 10, 2025 and May 14, 2026 inclusive (the “Class Period”).Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. ("Aardvark" or the "Company") (NASDAQ: AARD) securities between February 10, 2025 and May 14, 2026 inclusive (the “Class Period”).AARD Shareholder Alert: Aardvark Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
A securities class action alleges Aardvark Therapeutics' Chief Executive Officer, Chief Financial Officer, and former Chief Operating Officer controlled the safety representations about ARD-101 that preceded a Phase 3 pause and a full FDA clinical hold A securities class action alleges Aardvark Therapeutics' Chief Executive Officer, Chief Financial Officer, and former Chief Operating Officer controlled the safety representations about ARD-101 that preceded a Phase 3 pause and a full FDA clinical
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aard
AARD Spring & Stamping is a custom manufacturer based in Temecula, California, specializing in compression, torsion, and extension springs, as well as custom wire forms and stamping products. They offer a wide range of sizes and materials, catering to various industries including medical, communications, music, construction, lighting, and agricultu... Read More